Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZKY001 PK and Safety in Corneal Epithelial Defect
NCT07132437Phase 1Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of germinal peptide in Corneal epithelial defect, sponsored by Zhaoke Ophthalmology. Primary endpoint: Pharmacokinetic parameters at Day 6. Started Dec 2021; status: completed.
02
Drugs
germinal peptide
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT07132437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07132437.